HCV Alert: New Data on Resistance to DAAs and Implications for Therapy
The goal of this activity is to improve participants’ competence in applying emerging data on HCV drug resistance when providing care for patients with HCV infection.
This program is intended for physicians and other healthcare professionals involved in the management of patients infected with HCV.
- 0.75 AMA PRA Category 1 Credit(s)™
- 0.75 Attendance